Author

Rajdeep Kaur

National Institutes of HealthORCID 0009-0007-7587-7228Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Developmental Biology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Carlos R. FerreiraiD· 2 shared Giuliana AsconeiD· 2 shared Alessandro CorsiiD· 1 shared Arthur MacLarty· 1 shared Arwaa Mehran· 1 shared Cecilia RivasiD· 1 shared Dawn E. Watkins‐ChowiD· 1 shared Gene Elliot· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersDevelopmental Biology

Carlos R. FerreiraORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Developmental BiologybioRxivPreprintApr 14, 2026

Patient iPSC-Derived Cartilage Organoids Reveal Defective ECM Deposition and Altered Chondrogenic Trajectory in Saul-Wilson Syndrome

Sonal Mahajan, Sara Ancel, Giuliana Ascone…·Hudson H. Freeze

This study uses patient-derived iPSC cartilage organoids to show defective ECM deposition and altered chondrogenic trajectory in Saul-Wilson syndrome.

DOI 10.64898/2026.04.10.717608

humanscRNA-seq

𝕏 PostBluesky

Molecular BiologybioRxivPreprintNov 14, 2025

Disruption of the FGFR1-FGF23-Phosphate Axis and Targeted Therapy in a Murine Model of Osteoglophonic Dysplasia

Giuliana Ascone, Rajdeep Kaur, Arwaa Mehran…·Carlos R. Ferreira

This study creates a murine model of Osteoglophonic Dysplasia by introducing a gain-of-function FGFR1 variant, revealing pathogenic mechanisms and demonstrating therapeutic potential with infigratinib.

DOI 10.1101/2025.11.14.680268

mouseexperimental assay

𝕏 PostBluesky